Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Brunelli

Showing results (391-400 of 409) with videos related to

Pageof 41
Sort By:
Expert Review of Anticancer Therapy|April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.
Arab Journal of Urology|October 2, 2024
The 2012 Briganti nomogram predicts disease progression after surgery in high-risk prostate cancer patientsAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
European Urology|March 23, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 StudyRoberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, et al.
International Urology and Nephrology|March 30, 2024
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?Antonio Benito Porcaro, Alberto Bianchi, Andrea Panunzio, et al.
Cell Death & Disease|December 8, 2020
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumorsAlessandro Alaimo, Marco Lorenzoni, Paolo Ambrosino, et al.
Oncotarget|September 15, 2017
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutationAnna Caliò, John N Eble, Ondrej Hes, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Cancers|May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 StudySara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
Medicina (Kaunas, Lithuania)|November 27, 2024
Preoperative Briganti Nomogram Score and Risk of Prostate Cancer Progression After Robotic Surgery Beyond EAU Risk CategoriesAntonio Benito Porcaro, Rossella Orlando, Andrea Panunzio, et al.
Frontiers in Oncology|August 14, 2023
U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenarioSergio Bracarda, Roberto Iacovelli, Valentina Baldazzi, et al.
Pageof 41

Showing results (391-400 of 409) with videos related to

Sort By:
Pageof 41
Expert Review of Anticancer Therapy|April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.
Arab Journal of Urology|October 2, 2024
The 2012 Briganti nomogram predicts disease progression after surgery in high-risk prostate cancer patientsAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
European Urology|March 23, 2024
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 StudyRoberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, et al.
International Urology and Nephrology|March 30, 2024
Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?Antonio Benito Porcaro, Alberto Bianchi, Andrea Panunzio, et al.
Cell Death & Disease|December 8, 2020
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumorsAlessandro Alaimo, Marco Lorenzoni, Paolo Ambrosino, et al.
Oncotarget|September 15, 2017
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutationAnna Caliò, John N Eble, Ondrej Hes, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Cancers|May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 StudySara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
Medicina (Kaunas, Lithuania)|November 27, 2024
Preoperative Briganti Nomogram Score and Risk of Prostate Cancer Progression After Robotic Surgery Beyond EAU Risk CategoriesAntonio Benito Porcaro, Rossella Orlando, Andrea Panunzio, et al.
Frontiers in Oncology|August 14, 2023
U-CHANGE Project: a multidimensional consensus on how clinicians, patients and caregivers may approach together the new urothelial cancer scenarioSergio Bracarda, Roberto Iacovelli, Valentina Baldazzi, et al.
Pageof 41